Marathon of Hope – Québec consortium leadership and members share updates with the Network

On Thursday, September 18, leadership and researchers from the Marathon of Hope - Québec consortium presented their work to Network members as part of the MOHCCN seminar series

This series, which is being held periodically throughout the year, features virtual talks from MOHCCN leadership, investigators and trainees from each region, providing a platform for MOHCCN members to share their ongoing work in precision oncology with the wider Network. 

This event was co-chaired by Louise Bird, a member of the MOHCCN Patient Working Group, and by Véronique LeBlanc, PhD, Program Manager and Scientific Writer, MOHCCN.

Watch the full video

 

We regret that the audio quality of this recording is poor. We apologize for any inconvenience this may cause.

Speakers

Consortium Activities Update

Anne-Marie Mes-Masson, PhD, FRSC, FCAHS - Professor, Department of Medicine, Université de Montréal; Associate Scientific Director, Basic and Translational Research, Centre de recherche du Centre hospitalier de l'Université de Montréal (CR-CHUM); MOHCCN consortium lead (MOH-Q)

Morag Park, CQ, PhD, FRSC, FCAHS - Distinguished James McGill Professor, Departments of Oncology, Biochemistry, and Medicine, McGill University; Diane and Sal Guerrera Chair in Cancer Genetics; Director, Rosalind and Morris Goodman Cancer Institute, McGill University; MOHCCN consortium lead (MOH-Q)

Research Presentations

Precision Oncology at CR-CHUM and the Guy-Lafleur Program

Antoine Desilets, MD, MSc - Hematologist-oncologist, Department of Medicine, Centre hospitalier de l'Université de Montréal (CHUM); Assistant professor, Department of Medicine, Université de Montréal; MOHCCN Clinician-Scientist Awardee

Deciphering tumor heterogeneity and therapeutic vulnerabilities in rare metaplastic breast carcinoma: insights from the Gold Cohort

Hellen Kuasne, PhD - Research associate, Morag Park lab, McGill University